@pld89 I wouldn’t read into what they said they might further disclose a completion of the potency work that the company had flagged at the annual results CC would take a few months. It’s more in terms of clarifying what they would be or had started working on. That was the nature of my question to the company as I tried to assess their confidence in delivering the work to satisfy the FDA’s further data request.
I would re-read @dachopper ‘s very comprehensive first post on 6 Sep on the chronology of work completed since 2020 to get a better understanding of what they might now be doing. Doing an advanced search for MSB under his authorship will take you there.
@pld89 I wouldn’t read into what they said they might further...
-
- There are more pages in this discussion • 845 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
99.0¢ |
Change
0.010(1.02%) |
Mkt cap ! $1.130B | |||
| Open | High | Low | Value | Volume |
| 99.5¢ | $1.02 | 98.5¢ | $5.507M | 5.501M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 9996 | 99.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 99.5¢ | 18069 | 3 |
View Market Depth
| Last trade - 16.10pm 28/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |